Cargando…
338. Patients Living with HIV Infection Are Less Likely to Receive the Correct Intensity of Statin Therapy for Cardiovascular Disease Risk Reduction
BACKGROUND: Patients living with HIV (PLWH) at risk for atherosclerotic cardiovascular disease (ASCVD) should receive risk reduction interventions recommended in current guidelines. This includes routine ASCVD risk assessments and when eligible, statins selected and dosed to achieve appropriate low-...
Autores principales: | Schafer, Jason J, Patel, Roshni, Hastain, Nicholas V, Miano, Todd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810015/ http://dx.doi.org/10.1093/ofid/ofz360.411 |
Ejemplares similares
-
Multilevel Breast Reduction: A Retrospective Study of 338 Breast Reduction Surgeries
por: Borenstein, Amiram, et al.
Publicado: (2019) -
Beam-time for IS 338
por: CERN. Geneva. ISOLDE Experiments Committee
Publicado: (1996) -
OP 262-338
Publicado: (2005) -
New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins
por: Choi, Jah Yeon, et al.
Publicado: (2021) -
Statins: Cardiovascular Risk Reduction in Percutaneous Coronary Intervention—Basic and Clinical Evidence of Hyperacute Use of Statins
por: Morales-Villegas, Enrique C., et al.
Publicado: (2011)